Ameliora Wealth Management Ltd. Ayala Pharmaceuticals, Inc. Transaction History

Ameliora Wealth Management Ltd.

  • $240 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022
BUY
$0.82 - $1.97 $615 - $1,477
750 New
750 $1,000

Others Institutions Holding AYLA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Ayala Pharmaceuticals, Inc.

AYLA Quotes by TradingView
  • Ticker AYLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,833,300
  • Description
  • Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...
More about AYLA
Track This Portfolio

Track Ameliora Wealth Management Ltd. Portfolio

Follow Ameliora Wealth Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameliora Wealth Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Ameliora Wealth Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email